₨0.00
Yes
Cholecalciferol
Vitamin D Supplement
Cholecalciferol (vitamin D3) is formed in the skin under influence of UV rays and metabolized in two hydroxylation steps at first in the liver and then in the kidney tissue into the biological active metabolite 1,25-dihydroxy-cholecalciferol. 1,25-dihydroxy-cholecalciferol is involved fundamentally in the regulation of the calcium and phosphate balance together with parathyroid hormone and calcitonin.
a. Calcium Deficient Rickets: For children > 12months of age: 200,000 IU (1 ampoule) once per month repeated every 3 months until healing is established.b. Osteomalacia: Adults: 100,000 IU (1/2 ampoule) once a week for 6-12 months.c. Vitamin D Deficiency: i. Children > 12 months of age: 100,000 IU (1/2 ampoule) once a month for 3 months, followed by 400-1000 IU/day as maintenance;ii. Adults: 200,000 IU (1 ampoule) once a month for 2-3 months, followed by 100,000 IU (½ ampoule) once a month as maintenance.It is important to obtain calcium, phosphorus, and Alkaline Phosphatase levels before and 1 month after initiating therapy.
Acute symptoms : Arrhythmias, nausea, vomiting, psychic symptoms, and impaired consciousnesses.Chronic symptoms : Polyuria, polydipsia, weight loss, kidney stone formation, nephrocalcinosis, extraosseous calcifications
Thiazide diuretics , Phenytoin or barbiturates , glucocorticoids
Prevention of Vitamin D Deficiency due to malabsorption, drugs, certain chronic diseases, disorders of metabolism or other causes. Treatment of vitamin D deficiency states. These include the following: Rickets: In children , Osteomalacia: In adults.
It may not be used in the following conditions:Hypersensitivity to Cholecalciferol or any of the ingredients of the drug.Hypercalcemia and/or hypercalciuria.It should not be administered to patients : With a tendency towards the formation of kidney stones containing calcium ; With pseudohypoparathyroidism.
If other vitamin D containing drugs are administered, the dosage of Cholecalciferol must be taken into account. Additional administration of vitamin D or calcium should be carried out only under medical monitoring. In such cases the calcium levels in the serum and urine must be supervised.
It should be administered only with caution to patients with a disturbed renal calcium and phosphate excretion.
In the case of hypercalcemia or reduced kidney function the dosage must be reduced or the therapy discontinued.
It should be administered only with caution to patients suffering from sarcoidosis since the risk of transformation of vitamin D into its active metabolites is increased.
Always consult your physician before using any medicine.
Store this medicine at room temperature, away from direct light and heat.